Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
europe
tc
andreessen-horowitz
balderton capital
benevolentai
big data
biotech
biotech ipos
boston
boston blog main
boston top stories
business
clinical trials
cloud
dyne therapeutics
enterprise
entrepreneur
fda
funding daily
fundings & exits
health tech
life sciences
metacrine
mobile
myotonic dystrophy type 1
mytomorrows
national blog main
nonalcoholic steatohepatitis
os fund
rare disease drugs
rare diseases
salk institute
san diego blog main
san diego top stories
sofinnova partners
softbank ventures
startups
twoxar
ulcerative colitis
What
million
raised
5
×
stage
5
×
clinical
company
drug
funding
medicines
development
discovery
dutch
early
founded
medical
new
raises
startup
ac
accelerate
accelerating
access
achieve
actually
alto
amid
andreessen
approval
artificial
astrazeneca
backs
based
benevolentai
biopharmaceutical
braintree
brings
bryan
capital
china
chinese
collaboration
Language
unset
Current search:
stage
×
raised
×
@tech.eu
1 year ago
Chinese pharma giant backs Dutch medtech Xeltis with €15 million
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@techcrunch.com
4 years ago
BenevolentAI starts AI collaboration with AstraZeneca to accelerate drug discovery
@venturebeat.com
6 years ago
TwoXar raises $10 million from SoftBank, Andreessen Horowitz, and OS Fund to grow its AI drug discovery platform
@techcrunch.com
9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs